Literature DB >> 18787041

The expression of GPIHBP1, an endothelial cell binding site for lipoprotein lipase and chylomicrons, is induced by peroxisome proliferator-activated receptor-gamma.

Brandon S J Davies1, Hironori Waki, Anne P Beigneux, Emily Farber, Michael M Weinstein, Damien C Wilpitz, Li-Jung Tai, Ronald M Evans, Loren G Fong, Peter Tontonoz, Stephen G Young.   

Abstract

Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPIHBP1), a protein in the lymphocyte antigen 6 (Ly-6) family, plays a key role in the lipolytic processing of triglyceride-rich lipoproteins. GPIHBP1 binds lipoprotein lipase and chylomicrons and is expressed along the luminal surface of microvascular endothelial cells. Lipolysis is known to be regulated by metabolic factors and is controlled at multiple levels, including the number of LPL binding sites on capillaries. Here, we tested the possibility that GPIHBP1 expression could be regulated by dietary perturbations and by peroxisome proliferator-activated receptors (PPARs). Gpihbp1 transcript levels in the heart and in brown and white adipose tissue increased with fasting and returned toward baseline after refeeding. A PPARgamma agonist increased Gpihbp1 expression in adipose tissue, heart, and skeletal muscle, whereas PPARalpha and PPARdelta agonists had no effect. Gpihbp1 was expressed in endothelial cells of embryoid bodies generated from mouse embryonic stem cells, and Gpihbp1 expression in embryoid bodies was up-regulated by a PPARgamma agonist. Sequences upstream from exon 1 of Gpihbp1 contain a strong PPAR binding site, and that site exhibited activity in a luciferase reporter assay. Gpihbp1 transcript levels in brown and white adipose tissue were lower in endothelial cell PPARgamma knockout mice than in littermate control mice, suggesting that PPARgamma regulates Gpihbp1 expression in vivo. We conclude that GPIHBP1 is regulated by dietary factors and by PPARgamma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18787041      PMCID: PMC2582544          DOI: 10.1210/me.2008-0146

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  19 in total

1.  ES cell differentiation to the cardiac lineage.

Authors:  Kenneth R Boheler
Journal:  Methods Enzymol       Date:  2003       Impact factor: 1.600

Review 2.  From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions.

Authors:  Jérôme N Feige; Laurent Gelman; Liliane Michalik; Béatrice Desvergne; Walter Wahli
Journal:  Prog Lipid Res       Date:  2006-01-25       Impact factor: 16.195

Review 3.  Lipoprotein lipase: structure, function, regulation, and role in disease.

Authors:  James R Mead; Scott A Irvine; Dipak P Ramji
Journal:  J Mol Med (Berl)       Date:  2002-10-24       Impact factor: 4.599

4.  PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL.

Authors:  P Tontonoz; L Nagy; J G Alvarez; V A Thomazy; R M Evans
Journal:  Cell       Date:  1998-04-17       Impact factor: 41.582

5.  Differential regulation of expression of genes encoding uncoupling proteins 2 and 3 in brown adipose tissue during lactation in mice.

Authors:  N Pedraza; G Solanes; R Iglesias; M Vázquez; M Giralt; F Villarroya
Journal:  Biochem J       Date:  2001-04-01       Impact factor: 3.857

6.  Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons.

Authors:  Anne P Beigneux; Brandon S J Davies; Peter Gin; Michael M Weinstein; Emily Farber; Xin Qiao; Franklin Peale; Stuart Bunting; Rosemary L Walzem; Jinny S Wong; William S Blaner; Zhi-Ming Ding; Kristan Melford; Nuttaporn Wongsiriroj; Xiao Shu; Fred de Sauvage; Robert O Ryan; Loren G Fong; André Bensadoun; Stephen G Young
Journal:  Cell Metab       Date:  2007-04       Impact factor: 27.287

7.  Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle.

Authors:  Weimin He; Yaacov Barak; Andrea Hevener; Peter Olson; Debbie Liao; Jamie Le; Michael Nelson; Estelita Ong; Jerrold M Olefsky; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-05       Impact factor: 11.205

8.  Maternal PPAR gamma protects nursing neonates by suppressing the production of inflammatory milk.

Authors:  Yihong Wan; Alan Saghatelian; Ling-Wa Chong; Chun-Li Zhang; Benjamin F Cravatt; Ronald M Evans
Journal:  Genes Dev       Date:  2007-07-24       Impact factor: 11.361

Review 9.  GPIHBP1: an endothelial cell molecule important for the lipolytic processing of chylomicrons.

Authors:  Stephen G Young; Brandon S J Davies; Loren G Fong; Peter Gin; Michael M Weinstein; André Bensadoun; Anne P Beigneux
Journal:  Curr Opin Lipidol       Date:  2007-08       Impact factor: 4.776

Review 10.  Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis.

Authors:  I J Goldberg
Journal:  J Lipid Res       Date:  1996-04       Impact factor: 5.922

View more
  28 in total

Review 1.  Lipase maturation factor 1: a lipase chaperone involved in lipid metabolism.

Authors:  Miklós Péterfy
Journal:  Biochim Biophys Acta       Date:  2011-10-12

Review 2.  Genetic determinants of plasma triglycerides.

Authors:  Christopher T Johansen; Sekar Kathiresan; Robert A Hegele
Journal:  J Lipid Res       Date:  2010-11-01       Impact factor: 5.922

Review 3.  Emerging strategies of targeting lipoprotein lipase for metabolic and cardiovascular diseases.

Authors:  Werner J Geldenhuys; Li Lin; Altaf S Darvesh; Prabodh Sadana
Journal:  Drug Discov Today       Date:  2016-10-19       Impact factor: 7.851

4.  GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries.

Authors:  Brandon S J Davies; Anne P Beigneux; Richard H Barnes; Yiping Tu; Peter Gin; Michael M Weinstein; Chika Nobumori; Rakel Nyrén; Ira Goldberg; Gunilla Olivecrona; André Bensadoun; Stephen G Young; Loren G Fong
Journal:  Cell Metab       Date:  2010-07-07       Impact factor: 27.287

5.  A novel NanoBiT-based assay monitors the interaction between lipoprotein lipase and GPIHBP1 in real time.

Authors:  Shwetha K Shetty; Rosemary L Walzem; Brandon S J Davies
Journal:  J Lipid Res       Date:  2020-02-06       Impact factor: 5.922

Review 6.  Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 and the intravascular processing of triglyceride-rich lipoproteins.

Authors:  O Adeyo; C N Goulbourne; A Bensadoun; A P Beigneux; L G Fong; S G Young
Journal:  J Intern Med       Date:  2012-11-01       Impact factor: 8.989

7.  Adipose-specific lipoprotein lipase deficiency more profoundly affects brown than white fat biology.

Authors:  Itsaso Garcia-Arcos; Yaeko Hiyama; Konstantinos Drosatos; Kalyani G Bharadwaj; Yunying Hu; Ni Huiping Son; Sheila M O'Byrne; Chuchun L Chang; Richard J Deckelbaum; Manabu Takahashi; Marit Westerterp; Joseph C Obunike; Hongfeng Jiang; Hiroaki Yagyu; William S Blaner; Ira J Goldberg
Journal:  J Biol Chem       Date:  2013-03-31       Impact factor: 5.157

Review 8.  GPIHBP1, a GPI-anchored protein required for the lipolytic processing of triglyceride-rich lipoproteins.

Authors:  Anne P Beigneux; Brandon S J Davies; André Bensadoun; Loren G Fong; Stephen G Young
Journal:  J Lipid Res       Date:  2008-10-14       Impact factor: 5.922

9.  Adipose tissue endothelial cells from obese human subjects: differences among depots in angiogenic, metabolic, and inflammatory gene expression and cellular senescence.

Authors:  Aurélie Villaret; Jean Galitzky; Pauline Decaunes; David Estève; Marie-Adeline Marques; Coralie Sengenès; Patrick Chiotasso; Tamara Tchkonia; Max Lafontan; James L Kirkland; Anne Bouloumié
Journal:  Diabetes       Date:  2010-08-16       Impact factor: 9.461

10.  Peroxisome proliferator-activated receptor-gamma regulates the expression and function of very-low-density lipoprotein receptor.

Authors:  Huan Tao; Srikanth Aakula; Naji N Abumrad; Tahar Hajri
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-10-27       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.